These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22839360)

  • 41. Cryptococcus gattii Infection as the Major Clinical Manifestation in Patients with Autoantibodies Against Granulocyte-Macrophage Colony-Stimulating Factor.
    Wang SY; Lo YF; Shih HP; Ho MW; Yeh CF; Peng JJ; Ting HT; Lin KH; Huang WC; Chen YC; Chiu YH; Hsu CW; Tseng YT; Wang LS; Lei WY; Lin CY; Aoh Y; Chou CH; Wu TY; Ding JY; Lo CC; Lin YN; Tu KH; Lei WT; Kuo CY; Chi CY; Ku CL
    J Clin Immunol; 2022 Nov; 42(8):1730-1741. PubMed ID: 35947322
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A cell free assay system estimating the neutralizing capacity of GM-CSF antibody using recombinant soluble GM-CSF receptor.
    Urano S; Tazawa R; Nei T; Motoi N; Watanabe M; Igarashi T; Tomita M; Nakata K
    J Vis Exp; 2011 Jun; (52):. PubMed ID: 21730949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pulmonary alveolar proteinosis associated with anti-GM-CSF antibodies in a child: successful treatment with inhaled GM-CSF.
    Price A; Manson D; Cutz E; Dell S
    Pediatr Pulmonol; 2006 Apr; 41(4):367-70. PubMed ID: 16475176
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical significance of serum anti-GM-CSF autoantibody levels in autoimmune pulmonary alveolar proteinosis.
    Nishimura M; Yamaguchi E; Takahashi A; Asai N; Katsuda E; Ohta T; Ohtsuka Y; Kosaka K; Matsubara A; Tanaka H; Yokoe N; Kubo A; Konno S; Baba K
    Biomark Med; 2018 Feb; 12(2):151-159. PubMed ID: 29202602
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Granulocyte-macrophage colony-stimulating factor and pulmonary surfactant homeostasis.
    Reed JA; Whitsett JA
    Proc Assoc Am Physicians; 1998; 110(4):321-32. PubMed ID: 9686680
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A case of idiopathic pulmonary alveolar proteinosis accompanied by T-cell receptor gene rearrangement in bronchoalveolar lavage fluid cells.
    Hosokawa T; Yamaguchi E; Shirai S; Fuke S; Takaoka K; Kojima J; Nakata K; Nishimura M
    Respirology; 2004 Jun; 9(2):286-8. PubMed ID: 15182285
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pulmonary Alveolar Proteinosis: recent advances.
    Mazzone PJ; Jane Thomassen M; Kavuru MS
    Semin Respir Crit Care Med; 2002 Apr; 23(2):115-26. PubMed ID: 16088604
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Memory B cell pool of autoimmune pulmonary alveolar proteinosis patients contains higher frequency of GM-CSF autoreactive B cells than healthy subjects.
    Nei T; Urano S; Motoi N; Hashimoto A; Kitamura N; Tanaka T; Nakagaki K; Takizawa J; Kaneko C; Tazawa R; Nakata K
    Immunol Lett; 2019 Aug; 212():22-29. PubMed ID: 31195018
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autoantibodies against granulocyte-macrophage colony stimulating factor and interleukin-3 are rare in patients with Felty's syndrome.
    Hellmich B; Ciaglo A; Schatz H; Coakley G
    Ann Rheum Dis; 2004 Jul; 63(7):862-6. PubMed ID: 15194585
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness of granulocyte-macrophage colony-stimulating factor therapy in autoimmune pulmonary alveolar proteinosis: a meta-analysis of observational studies.
    Khan A; Agarwal R; Aggarwal AN
    Chest; 2012 May; 141(5):1273-1283. PubMed ID: 22016491
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rational design, analysis, and potential utility of GM-CSF antagonists.
    Monfardini C; Kieber-Emmons T; VonFeldt JM; Godillot AP; Voet D; Weiner DB; Williams WV
    Proc Assoc Am Physicians; 1996 Nov; 108(6):420-31. PubMed ID: 8956365
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation.
    Hansen G; Hercus TR; McClure BJ; Stomski FC; Dottore M; Powell J; Ramshaw H; Woodcock JM; Xu Y; Guthridge M; McKinstry WJ; Lopez AF; Parker MW
    Cell; 2008 Aug; 134(3):496-507. PubMed ID: 18692472
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nocardia-induced granulocyte macrophage colony-stimulating factor is neutralized by autoantibodies in disseminated/extrapulmonary nocardiosis.
    Rosen LB; Rocha Pereira N; Figueiredo C; Fiske LC; Ressner RA; Hong JC; Gregg KS; Henry TL; Pak KJ; Baumgarten KL; Seoane L; Garcia-Diaz J; Olivier KN; Zelazny AM; Holland SM; Browne SK
    Clin Infect Dis; 2015 Apr; 60(7):1017-25. PubMed ID: 25472947
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody.
    Sanders P; Young S; Sanders J; Kabelis K; Baker S; Sullivan A; Evans M; Clark J; Wilmot J; Hu X; Roberts E; Powell M; Núñez Miguel R; Furmaniak J; Rees Smith B
    J Mol Endocrinol; 2011 Apr; 46(2):81-99. PubMed ID: 21247981
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An open-label trial of rituximab therapy in pulmonary alveolar proteinosis.
    Kavuru MS; Malur A; Marshall I; Barna BP; Meziane M; Huizar I; Dalrymple H; Karnekar R; Thomassen MJ
    Eur Respir J; 2011 Dec; 38(6):1361-7. PubMed ID: 21478218
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pulmonary alveolar proteinosis.
    Khan A; Agarwal R
    Respir Care; 2011 Jul; 56(7):1016-28. PubMed ID: 21496372
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A combination therapy of whole lung lavage and GM-CSF inhalation in pulmonary alveolar proteinosis.
    Yamamoto H; Yamaguchi E; Agata H; Kandatsu N; Komatsu T; Kawai S; Baba K; Awaya T; Nishikomori R; Tsurusawa M; Nakata K
    Pediatr Pulmonol; 2008 Aug; 43(8):828-30. PubMed ID: 18618617
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systemic lupus erythematosus complicating autoimmune pulmonary alveolar proteinosis that was worsened by immunosuppressive therapy.
    Nagasawa J; Kurasawa K; Maezawa R; Owada T; Hanaoka R; Fukuda T
    Lupus; 2013 Sep; 22(10):1060-3. PubMed ID: 23886640
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Crystal structure of the Fab region of a neutralizing antibody against granulocyte-macrophage colony-stimulating factor.
    Angkawidjaja C; Torashima T
    Acta Crystallogr F Struct Biol Commun; 2019 Oct; 75(Pt 10):634-639. PubMed ID: 31584011
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Are neutralizing anti-GM-CSF autoantibodies present in all healthy persons?
    Meager A; Cludts I; Thorpe R; Wadhwa M
    Blood; 2010 Jan; 115(2):433-4. PubMed ID: 20075174
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.